Long-term results of the international adjuvant lung cancer trial evaluating adjuvant Cisplatin-based chemotherapy in resected lung cancer

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Rodrigo ArriagadaThierry Le Chevalier

Abstract

PURPOSE Based on 5-year or shorter-term follow-up data in recent randomized trials, adjuvant cisplatin-based chemotherapy is now generally recommended after complete surgical resection for patients with non-small-cell lung cancer (NSCLC). We evaluated the results of the International Adjuvant Lung Cancer Trial study with three additional years of follow-up. PATIENTS AND METHODS Patients with completely resected NSCLC were randomly assigned to three or four cycles of cisplatin-based chemotherapy or to observation. Cox models were used to evaluate treatment effect according to follow-up duration. Results The trial included 1,867 patients with a median follow-up of 7.5 years. Results showed a beneficial effect of adjuvant chemotherapy on overall survival (hazard ratio [HR], 0.91; 95% CI, 0.81 to 1.02; P = .10) and on disease-free survival (HR, 0.88; 95% CI, 0.78 to 0.98; P = .02). However, there was a significant difference between the results of overall survival before and after 5 years of follow-up (HR, 0.86; 95% CI, 0.76 to 0.97; P = .01 v HR, 1.45; 95% CI, 1.02 to 2.07; P = .04) with P = .006 for interaction. Similar results were observed for disease-free survival. The analysis of non-lung cancer deaths for the whole period sh...Continue Reading

References

Apr 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S OsantoJ Hermans
Aug 1, 1996·Controlled Clinical Trials·M Schemper, T L Smith
Jul 31, 2003·Drugs·Uzair B Chaudhary, Jason R Haldas
Oct 2, 2003·Journal of the National Cancer Institute·Giorgio V ScagliottiUNKNOWN Adjuvant Lung Project Italy/European Organisation for Research Treatment of Cancer-Lung Cancer Cooperative Group Investigato
Dec 4, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·R ArriagadaM R Baeza
Jan 23, 2004·The New England Journal of Medicine·Rodrigo ArriagadaUNKNOWN International Adjuvant Lung Cancer Trial Collaborative Group
Jun 18, 2004·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·D WallerS G Spiro
May 13, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·E FelipUNKNOWN ESMO Guidelines Task Force
Jun 24, 2005·The New England Journal of Medicine·Timothy WintonUNKNOWN National Cancer Institute of the United States Intergroup JBR.10 Trial Investigators
Jul 8, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bruce E Johnson, Michael S Rabin
Oct 21, 2005·Chest·Antonio L VisbalFrances A Shepherd
Sep 8, 2006·The New England Journal of Medicine·Ken A OlaussenUNKNOWN IALT Bio Investigators
Apr 5, 2007·Journal of the National Cancer Institute·Sophie D FossåLois B Travis
May 29, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Pierre PignonUNKNOWN LACE Collaborative Group
Jul 22, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin FrühFrances A Shepherd
Dec 17, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·R ArriagadaF de Vathaire
May 19, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Jean-Pierre PignonUNKNOWN MACH-NC Collaborative Group

❮ Previous
Next ❯

Citations

Feb 20, 2009·Current Treatment Options in Oncology·Rachel E Sanborn
May 28, 2010·Revue de pneumologie clinique·A PaumierE Giroux Leprieur
Aug 31, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B BesseJ C Soria
Sep 26, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Besse, T Le Chevalier
Nov 20, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M KreuterUNKNOWN TREAT investigators
Mar 16, 2012·Interactive Cardiovascular and Thoracic Surgery·Michael PoullisNeeraj Mediratta
May 9, 2009·American Journal of Respiratory and Critical Care Medicine·Sarita Dubey, Charles A Powell
Sep 10, 2011·Therapeutic Advances in Medical Oncology·Georgios IoannidisJohn Souglakos
Dec 31, 2011·Journal of Experimental & Clinical Cancer Research : CR·Maria BonomiEmilio Bria
Aug 5, 2010·The Oncologist·Randeep SanghaCharles A Butts
Oct 14, 2011·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Marina PetrovićGordana Kostić
Jun 23, 2011·Clinical Medicine Insights. Oncology·Bryan A Faller, Trailokya N Pandit
Oct 18, 2013·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Marc RiquetFrançoise Le Pimpec-Barthes
Jun 3, 2014·BMC Medical Research Methodology·Federico Rotolo, Stefan Michiels
Feb 11, 2014·Carcinogenesis·Ajaya Kumar RekaVenkateshwar G Keshamouni
Sep 7, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·F RotoloUNKNOWN IALT Collaborative Group
Dec 15, 2010·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Giuseppe Luigi BannaElisa Zanon
Aug 15, 2013·World Journal of Surgery·Tomoyoshi TakenakaSadanori Takeo
Oct 27, 2010·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·José Manuel Trigo PérezUNKNOWN SEOM (Spanish Society for Medical Oncology)
Feb 2, 2016·Future Oncology·Diego Marquez-Medina, Sanjay Popat
May 28, 2013·Expert Opinion on Drug Metabolism & Toxicology·Orazio CaffoEnzo Galligioni
Mar 31, 2015·Acta Oncologica·Samuel KvarnbrinkHåkan Hedman
Jul 17, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jamie E ChaftNaiyer A Rizvi
Jun 29, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thomas E StinchcombeRamaswamy Govindan
May 14, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·John M VarlottoMalcolm M DeCamp
May 26, 2011·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Razvan DiaconescuRenaud Whittom
May 27, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Wei OuSi-yu Wang
Jun 29, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Thomas E StinchcombeRamaswamy Govindan
Jul 28, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Daniel Morgensztern, Ramaswamy Govindan
Jul 17, 2013·The Journal of Thoracic and Cardiovascular Surgery·Chris R KelseyJohn M Varlotto
Jul 3, 2013·Critical Reviews in Oncology/hematology·Jordi RemonMontserrat Zanui
Aug 13, 2013·Thoracic Surgery Clinics·R Taylor Ripley, Valerie W Rusch
May 4, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hua LiangCheng Xiang Yang
Aug 13, 2011·Clinical Lung Cancer·David P Carbone, Enriqueta Felip
Aug 25, 2010·International Journal of Radiation Oncology, Biology, Physics·John M VarlottoMalcolm M DeCamp

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved